46/120
1.9 / 5 stars
All 120 Win/Lose results shown below
RDNT Roast Me summary
RadNet, Inc. (RDNT). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseRDNT / S&P 10.34% / 15.20% |
WinRDNT / S&P 18.92% / 15.00% |
LoseRDNT / S&P RDNT unavailable / 50.40% |
| 2026-Q11/3 |
LoseRDNT / S&P -21.67% / -4.33% |
WinRDNT / S&P 14.72% / 11.30% |
LoseRDNT / S&P RDNT unavailable / 27.70% |
| 2025-Q41/3 |
LoseRDNT / S&P -6.38% / 2.65% |
WinRDNT / S&P 11.51% / 9.00% |
LoseRDNT / S&P -725.00% / 13.40% |
| 2025-Q32/3 |
WinRDNT / S&P 33.91% / 8.12% |
WinRDNT / S&P 11.09% / 4.61% |
LoseRDNT / S&P RDNT unavailable / 13.45% |
| 2025-Q22/3 |
WinRDNT / S&P 14.46% / 10.94% |
WinRDNT / S&P 11.33% / 4.83% |
LoseRDNT / S&P -242.86% / 10.63% |
| 2025-Q11/3 |
LoseRDNT / S&P -28.81% / -4.27% |
WinRDNT / S&P 12.76% / 4.98% |
LoseRDNT / S&P -243.33% / 10.57% |
| 2024-Q41/3 |
LoseRDNT / S&P 0.65% / 2.41% |
WinRDNT / S&P 13.18% / 5.25% |
LoseRDNT / S&P -20.00% / 6.15% |
| 2024-Q32/3 |
WinRDNT / S&P 17.77% / 5.89% |
WinRDNT / S&P 12.20% / 5.89% |
LoseRDNT / S&P RDNT unavailable / 6.11% |
| 2024-Q22/3 |
WinRDNT / S&P 21.09% / 4.28% |
WinRDNT / S&P 12.14% / 5.38% |
LoseRDNT / S&P RDNT unavailable / 5.12% |
| 2024-Q12/3 |
WinRDNT / S&P 39.95% / 10.56% |
WinRDNT / S&P 12.10% / 5.71% |
LoseRDNT / S&P RDNT unavailable / 5.59% |
| 2023-Q42/3 |
WinRDNT / S&P 23.34% / 11.69% |
WinRDNT / S&P 13.05% / 6.81% |
LoseRDNT / S&P -70.59% / 7.78% |
| 2023-Q31/3 |
LoseRDNT / S&P -13.58% / -3.27% |
WinRDNT / S&P 14.56% / 7.52% |
LoseRDNT / S&P -109.09% / -5.03% |
| 2023-Q22/3 |
WinRDNT / S&P 30.32% / 8.74% |
WinRDNT / S&P 12.20% / 9.50% |
LoseRDNT / S&P -162.50% / -8.57% |
| 2023-Q11/3 |
WinRDNT / S&P 32.93% / 7.50% |
LoseRDNT / S&P 10.24% / 10.77% |
LoseRDNT / S&P -175.00% / -15.69% |
| 2022-Q40/3 |
LoseRDNT / S&P -7.47% / 7.56% |
LoseRDNT / S&P 8.74% / 11.88% |
LoseRDNT / S&P -63.04% / -17.99% |
| 2022-Q31/3 |
WinRDNT / S&P 17.77% / -4.88% |
LoseRDNT / S&P 6.94% / 13.47% |
LoseRDNT / S&P -83.08% / -1.41% |
| 2022-Q20/3 |
LoseRDNT / S&P -22.75% / -16.10% |
LoseRDNT / S&P 9.05% / 13.71% |
LoseRDNT / S&P -14.89% / 11.04% |
| 2022-Q12/3 |
LoseRDNT / S&P -25.71% / -4.60% |
WinRDNT / S&P 21.34% / 15.97% |
WinRDNT / S&P 52.38% / 42.23% |
| 2021-Q41/3 |
LoseRDNT / S&P 2.73% / 11.03% |
WinRDNT / S&P 22.69% / 15.00% |
LoseRDNT / S&P RDNT unavailable / 96.40% |
| 2021-Q31/3 |
LoseRDNT / S&P -13.00% / 0.58% |
WinRDNT / S&P 21.14% / 10.77% |
LoseRDNT / S&P RDNT unavailable / 69.42% |
| 2021-Q22/3 |
WinRDNT / S&P 54.90% / 8.55% |
WinRDNT / S&P 17.20% / 6.58% |
LoseRDNT / S&P RDNT unavailable / 51.81% |
| 2021-Q12/3 |
WinRDNT / S&P 11.14% / 6.17% |
LoseRDNT / S&P -5.03% / -1.06% |
WinRDNT / S&P 600.00% / 7.39% |
| 2020-Q41/3 |
WinRDNT / S&P 27.49% / 12.15% |
LoseRDNT / S&P -7.13% / -3.72% |
LoseRDNT / S&P -200.00% / -33.42% |
| 2020-Q30/3 |
LoseRDNT / S&P -3.28% / 8.93% |
LoseRDNT / S&P -4.12% / -2.04% |
LoseRDNT / S&P -132.35% / -27.10% |
| 2020-Q22/3 |
WinRDNT / S&P 51.00% / 20.54% |
WinRDNT / S&P 0.53% / -0.46% |
LoseRDNT / S&P -138.89% / -27.11% |
| 2020-Q11/3 |
LoseRDNT / S&P -48.23% / -19.60% |
WinRDNT / S&P 14.66% / 3.47% |
LoseRDNT / S&P -95.89% / -14.75% |
| 2019-Q42/3 |
WinRDNT / S&P 41.36% / 9.07% |
WinRDNT / S&P 18.36% / 5.36% |
LoseRDNT / S&P -56.06% / 2.99% |
| 2019-Q32/3 |
WinRDNT / S&P 4.13% / 1.70% |
WinRDNT / S&P 10.83% / 5.02% |
LoseRDNT / S&P RDNT unavailable / 0.21% |
| 2019-Q22/3 |
WinRDNT / S&P 11.30% / 4.30% |
WinRDNT / S&P 9.15% / 6.64% |
LoseRDNT / S&P RDNT unavailable / 8.65% |
| 2019-Q11/3 |
WinRDNT / S&P 21.83% / 13.65% |
LoseRDNT / S&P 7.92% / 8.12% |
LoseRDNT / S&P RDNT unavailable / 14.29% |
| 2018-Q40/3 |
LoseRDNT / S&P -32.43% / -13.52% |
LoseRDNT / S&P 5.74% / 9.05% |
LoseRDNT / S&P RDNT unavailable / 18.23% |
| 2018-Q30/3 |
LoseRDNT / S&P 0.33% / 7.71% |
LoseRDNT / S&P RDNT unavailable / 10.21% |
LoseRDNT / S&P RDNT unavailable / 19.06% |
| 2018-Q21/3 |
WinRDNT / S&P 4.17% / 3.43% |
LoseRDNT / S&P RDNT unavailable / 9.03% |
LoseRDNT / S&P RDNT unavailable / 14.46% |
| 2018-Q11/3 |
WinRDNT / S&P 42.57% / -0.76% |
LoseRDNT / S&P RDNT unavailable / 7.68% |
LoseRDNT / S&P RDNT unavailable / 12.46% |
| 2017-Q40/3 |
LoseRDNT / S&P -12.55% / 6.64% |
LoseRDNT / S&P 4.26% / 7.03% |
LoseRDNT / S&P -100.00% / 13.82% |
| 2017-Q31/3 |
WinRDNT / S&P 49.03% / 4.48% |
LoseRDNT / S&P RDNT unavailable / 5.68% |
LoseRDNT / S&P RDNT unavailable / 17.57% |
| 2017-Q21/3 |
WinRDNT / S&P 31.36% / 3.09% |
LoseRDNT / S&P RDNT unavailable / 4.83% |
LoseRDNT / S&P RDNT unavailable / 17.74% |
| 2017-Q10/3 |
LoseRDNT / S&P -8.53% / 6.07% |
LoseRDNT / S&P RDNT unavailable / 3.67% |
LoseRDNT / S&P RDNT unavailable / 13.32% |
| 2016-Q40/3 |
LoseRDNT / S&P -12.84% / 3.82% |
LoseRDNT / S&P RDNT unavailable / 2.09% |
LoseRDNT / S&P -11.76% / 7.05% |
| 2016-Q31/3 |
WinRDNT / S&P 38.58% / 3.85% |
LoseRDNT / S&P RDNT unavailable / 0.20% |
LoseRDNT / S&P RDNT unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | RDNT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 4.08% | 20.78% |
| Annualized return | 4.08% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | RDNT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 142.58% | 83.14% |
| Annualized return | 19.39% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | RDNT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 1009.80% | 319.30% |
| Annualized return | 27.21% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |